Inhibition of Prolyl Hydroxylases Increases Erythropoietin Production in ESRD

The reasons for inadequate production of erythropoietin (EPO) in patients with ESRD are poorly understood. A better understanding of EPO regulation, namely oxygen-dependent hydroxylation of the hypoxia-inducible transcription factor (HIF), may enable targeted pharmacological intervention. Here, we t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bernhardt, Wanja M., Wiesener, Michael S., Scigalla, Paul, Chou, James, Schmieder, Roland E., Günzler, Volkmar, Eckardt, Kai-Uwe
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Nephrology 2010
Assuntos:
Clinical Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3014028/
https://ncbi.nlm.nih.gov/pubmed/21115615
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2010010116
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados